UNSPSC 85782544: Alteration of left upper leg with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to alteration of left upper leg with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0Y0D37Z

UNSPSC 85782544, Alteration of left upper leg with autologous tissue substitute, percutaneous approach, is a Commodity code that does not align with state and local government procurement activity in the source material. The code describes a specific surgical procedure using autologous tissue; however, the recent state and local opportunities tagged under this code do not solicit surgical services of this type. Instead, the opportunities seek independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, surgical benefit carve-out programs, emergency and specialty medical services for youth in custody, and temporary health professional staffing—none of which constitute the orthopedic surgical intervention the code nominally describes.

The mismatch between the code's scope and the actual work being solicited suggests the code is either misapplied by the issuing bodies or used as a catch-all tag for health and medical services without specificity. Geographic activity spans Arizona, California, Florida, and Washington, across city retirement offices, county health systems, state transportation departments, and county procurement offices. Recent opportunities include the City of Phoenix Retirement Office's request for independent medical evaluation services (RFP, due October 16, 2026), the Washington State Department of Transportation's occupational medical surveillance RFP (due October 9, 2026), and the County of Santa Clara Health System's temporary health professional staffing qualification pool (due October 7, 2026). Practitioners should verify code assignment before pursuing opportunities under this Commodity designation, as the tag does not reliably signal work in the surgical or tissue-substitute domain.